Codexis announced the appointment of Carole Cobb, MBA, to the Company’s Strategic Advisory Board. Ms. Cobb is the former COO at GreenLight Biosciences, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXS:
- Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
- Biotech Alert: Searches spiking for these stocks today
- A New Cause for Concern: Codexis Adds a New Corporate Activity and Growth Risk
- Codexis upgraded to Buy at Benchmark after Q4 revenue and 2024 guidance
- Codexis upgraded to Buy from Hold at Benchmark
